What is cbdMD?
Founded in 2015, cbdMD has established itself as a key player in the cannabidiol industry, offering a diverse portfolio that includes CBD tinctures, capsules, gummies, topicals, bath bombs, and pet products. The company's commitment to quality and accessibility has positioned it as a go-to source for consumers seeking CBD solutions. Its operations are centered in North Carolina, contributing to the regional economic landscape while serving a national market.
How much funding has cbdMD raised?
cbdMD has raised a total of $18.3M across 2 funding rounds:
Debt
$1M
Stock Offering
$17.3M
Debt (2020): $1M with participation from PPP
Stock Issuance/Offering (2020): $17.3M led by Undisclosed
What's next for cbdMD?
The recent major strategic investment into cbdMD signals a strong confidence from stakeholders in the company's future trajectory and market potential. This infusion of capital is expected to fuel further expansion and development of its product lines, enhance its market reach, and potentially support research and development initiatives. As the CBD market continues to mature and evolve, cbdMD appears poised to leverage this backing for sustained growth and innovation, solidifying its position as a leader in the enterprise-level wellness sector.
See full cbdMD company page
